Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1285-1293

  Lazzarotto, T ^a   Guerra, B ^b   Gabrielli, L ^a   Lanari, M ^c   Landini, M P ^a  

^a Microbiology Unit   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c La Scaletta Hospital   (Italy)

Author keywords

Amniocentesis; Cytomegalovirus; Pregnancy; Prevention; Serological diagnosis

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; VALACICLOVIR;

AMNIOCENTESIS; AMNION FLUID; ANTIBODY BLOOD LEVEL; ASYMPTOMATIC INFECTION; CORDOCENTESIS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; EARLY INTERVENTION; FETUS ECHOGRAPHY; FETUS MALFORMATION; GESTATIONAL AGE; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; INTRAUTERINE INFECTION; MULTICENTER STUDY (TOPIC); NEWBORN INFECTION; PERSONAL HYGIENE; PHASE 2 CLINICAL TRIAL (TOPIC); PLACENTAL TRANSFER; PREGNANCY; PRENATAL DIAGNOSIS; PRIMARY INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SEROLOGY; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; VIROLOGY; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 80051876843     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03564.x     Document Type: Review

References (42)

1. Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010; 20: 311-326.
2. Peckham CS. Cytomegalovirus infection: congenital and neonatal disease. Scand J Infect Dis Suppl 1991; 80: 82-87.
3. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253-276.
4. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000; 11: 283-290.
5. Bodéus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 1999; 93: 658-660.
6. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 35: 216-220.
7. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal and mortality. Pediatr Infect Dis J 1992; 11: 93-99.
8. Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 2006; 193: 783-787.
9. Daiminger A, Bäder U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 2005; 112: 166-172.
10. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186: 553-557.
11. Hadar E, Yogev Y, Melamed N, Chen R, Amir J, Pardo J. Periconceptional cytomegalovirus infection: pregnancy outcome and rate of vertical transmission. Prenat Diagn 2010; 30: 1213-1216.
12. Guerra B, Simonazzi G, Banfi A et al. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol 2007; 196: 221.e1-221.e6.
13. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 2004; 145: 485-491.
14. Vauloup-Fellous C, Picone O, Cordier AG et al. Does hygiene counselling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009; 46S: S49-S53.
15. Pass RF, Zhang C, Evans A et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360: 1191-1199.
16. Nigro G, Adler SP, La Torre R, Best AM; Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353: 1350-1362.
17. Jacquemard F, Yamamoto M, Costa JM et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 114: 1113-1121.
18. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680-715.
19. De Paschale M, Agrappi C, Manco MT, Clerici P. Positive predictive value of anti-HCMV IgM as an index of primary infection. J Virol Methods 2010; 168: 121-125.
20. Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: comparison between a new Western blot, conventional Western blot, and nine commercially available assays. Clin Diagn Lab Immunol 1997; 4: 483-486.
21. De Carolis S, Santucci S, Botta A et al. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome. Lupus 2010; 19: 844-849.
22. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008; 41: 192-197.
23. Lazzarotto T, Ripalti A, Bergamini G et al. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol 1998; 36: 3337-3341.
24. Macé M, Sissoeff L, Rudent A, Grangeot-Keros L. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat Diagn 2004; 24: 861-863.
25. Lazzarotto T, Varani S, Spezzacatena P et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 2000; 13: 137-141.
26. Enders G, Bäder U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001; 21: 362-377.
27. Guisasola ME, Ramos B, Sanz JC, García-Bermejo I, De Ory Manchón F. Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection. APMIS 2010; 118: 991-993.
28. Grangeot-Keros L, Mayaux MJ, Lebon P et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary infection in pregnant women. J Infect Dis 1997; 175: 944-946.
29. Kanengisser-Pines B, Hazan Y, Pines G, Appelman Z. High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy. J Perinat Med 2009; 37: 15-18.
30. Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 2010; 48: 255-259.
31. Grangeot-Keros L. CMV IgG avidity: value and limits. Roche Symposium, 3CMV- Congenital Cytomegalovirus Conference, 23-25 September 2010, Paris-France.
32. Eggers M, Bader U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000; 60: 324-330.
33. Coll O, Benoist G, Ville Y et al. Guidelines on CMV congenital infection. J Perinat Med 2009; 37: 433-445.
34. Peled Y, Yogev Y, Oron G, Amir J, Pardo J. Suggested algorithm for cytomegalovirus surveillance in low-risk pregnancies. J Matern Fetal Neonatal Med 2011; Early Online, 1-4.
35. Guerra B, Simonazzi G, Puccetti C et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008; 198: 380.e1-380.e7.
36. Benoist G, Salomon LJ, Mohlo M, Suarez B, Jacquemard F, Ville Y. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008; 115: 823-829.
37. Guerra B, Lazzarotto T, Quarta S et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000; 183: 476-482.
38. Donner C, Liesnard C, Brancart F, Rodesch F. Accuracy of amniotic fluid testing before 21weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn 1994; 14: 1055-1059.
39. Revello MG, Furione M, Zavattoni M et al. Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008; 197: 593-596.
40. Lazzarotto T, Gabrielli L, Baccolini F et al. Prenatal diagnosis of congenital cytomegalovirus (CMV) infection and outcome in 598 pregnant women undergoing a primary CMV infection. OR#10.2. In Abstracts of the 12th International CMV/BetaHerpesvirus Workshop, May 10-14 2009, Boston-USA.
41. Romanelli RM, Magny JF, Jacquemard F. Prognostic markers of symptomatic congenital cytomegalovirus infection. Braz J Infect Dis 2008; 12: 38-43.
42. Fabbri E, Revello MG, Furione M et al. Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. BJOG 2011; 118: 448-456.